share_log

Theravance Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Irenic Capital Management LP(5.5%),Irenic Capital Evergreen Master Fund LP(5.5%), etc.

Theravance Biopharma | SC 13G:超过5%持股股东披露文件-Irenic Capital Management LP(5.5%),Irenic Capital Evergreen Master Fund LP(5.5%)等

SEC announcement ·  02/14 16:04
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息